June 18, 2020

SAN RAMON, Calif., June 18, 2020—CooperVision has named Simon Seshadri as Senior Vice President, Global Marketing, effective immediately. He is responsible for executive leadership and management for the company’s Global Marketing organization, including driving product pipeline innovation and advancing standards for inbound and outbound marketing functions.

Seshadri was most recently CooperVision’s Vice President of Marketing, North America, where he also led commercial activation across key customer groups. He joined the company in 2014 as Senior Director, Global Brand Marketing for frequent replacement products, and was instrumental in introducing the Biofinity Energys® and Avaira Vitality contact lens brands. Prior to that, he served in international marketing roles with GE Healthcare and Bausch & Lomb, as well as working for Philips Consumer Lifestyle in Japan and North America and Boots Healthcare in the United Kingdom and Japan.

“Simon has worked on multinational brand programs within eye health, as well as outside the category with highly respected healthcare products including Sonicare, Clearasil, and Strepsils. These all required precise navigation of the business-to-provider-to-consumer model and an intimate understanding of healthcare professionals’ and consumers’ varying needs. His globally influenced vision and experiences will strengthen our partnerships with the eye care profession and spark additional market growth,” said Jerry Warner, Executive Vice President and President, Americas and Commercial Functions at CooperVision.

Seshadri earned his MBA from the London Business School and a Bachelor of Commerce (Marketing) from the University of British Columbia. He resides with his family in Pleasanton, Calif. and remains based at CooperVision’s headquarters in San Ramon, Calif.

He succeeds Guy Whittaker, who earlier this year was promoted to the position of CooperVision’s Senior Vice President, Global Strategy and Lifecycle Management.

# # #

About CooperVision
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of daily disposable, two-week and monthly contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism, presbyopia and childhood myopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.

About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com

Media Contact
Mike McDougall, APR, Fellow PRSA, McDougall Communications
mike@mcdougallpr.com or +1-585-545-1815 (mobile)